Literature DB >> 7332907

Estrogen induced growth of human breast cancer cells (MCF-7) in athymic nude mice is enhanced by secretions from a transplantable pituitary tumor.

C W Welsch, E L Swim, M J McManus, A C White, C M McGrath.   

Abstract

MCF-7, a human breast carcinoma cell line, was maintained s.c. in female athymic nude mice for a period of 5-6 weeks. Administration of estrogen (s.c. pellet of 17 beta-estradiol and estrone in drinking water, 0.5 mg/l) to these mice resulted in sustained (P less than 0.001) growth of MCF-7 tumors. Grafting of a prolactin and growth hormone secreting rat pituitary tumor to the estrogen-treated mice resulted in an increased (P less than 0.05) rate of MCF-7 tumor growth. MCF-7 did not grow in athymic nude mice grafted with rat pituitary tumor alone or in mice without hormone treatment (controls). Thus, secretions of pituitary hormones alone are not capable of promoting in vivo growth of MCF-7 although such secretions significantly enhance estrogen-induced growth of this cell line. A synergism between pituitary hormones and estrogen for in vivo growth of a human breast carcinoma has been demonstrated in this study.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7332907     DOI: 10.1016/0304-3835(81)90160-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Animal modeling of human breast tumors: limitations in the use of estrogen pellet implants.

Authors:  R D Blumenthal; J J Jordan; W H McLaughlin; W D Bloomer
Journal:  Breast Cancer Res Treat       Date:  1988-04       Impact factor: 4.872

2.  Identification of estrogen-inducible growth factors (estromedins) for rat and human mammary tumor cells in culture.

Authors:  T Ikeda; Q F Liu; D Danielpour; J B Officer; M Iio; F E Leland; D A Sirbasku
Journal:  In Vitro       Date:  1982-12

3.  Identification of a pituitary factor responsible for enhancement of plasminogen activator activity in breast tumor cells.

Authors:  R Mira-y-Lopez; J Joseph-Silverstein; D B Rifkin; L Ossowski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells.

Authors:  Y F Zhai; W J Esselman; C S Oakley; C C Chang; C W Welsch
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 5.  Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.

Authors:  R Clarke
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 6.  Considerations in the use of nude mice for cancer research.

Authors:  F E Sharkey; J Fogh
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

Review 7.  Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

Authors:  Lacey E Dobrolecki; Susie D Airhart; Denis G Alferez; Samuel Aparicio; Fariba Behbod; Mohamed Bentires-Alj; Cathrin Brisken; Carol J Bult; Shirong Cai; Robert B Clarke; Heidi Dowst; Matthew J Ellis; Eva Gonzalez-Suarez; Richard D Iggo; Peter Kabos; Shunqiang Li; Geoffrey J Lindeman; Elisabetta Marangoni; Aaron McCoy; Funda Meric-Bernstam; Helen Piwnica-Worms; Marie-France Poupon; Jorge Reis-Filho; Carol A Sartorius; Valentina Scabia; George Sflomos; Yizheng Tu; François Vaillant; Jane E Visvader; Alana Welm; Max S Wicha; Michael T Lewis
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

8.  The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells.

Authors:  Igor L Bado; Weijie Zhang; Jingyuan Hu; Zhan Xu; Hai Wang; Poonam Sarkar; Lucian Li; Ying-Wooi Wan; Jun Liu; William Wu; Hin Ching Lo; Ik Sun Kim; Swarnima Singh; Mahnaz Janghorban; Aaron M Muscarella; Amit Goldstein; Purba Singh; Hyun-Hwan Jeong; Chaozhong Liu; Rachel Schiff; Shixia Huang; Matthew J Ellis; M Waleed Gaber; Zbigniew Gugala; Zhandong Liu; Xiang H-F Zhang
Journal:  Dev Cell       Date:  2021-04-19       Impact factor: 12.270

9.  The polybrominated diphenyl ether mixture DE-71 is mildly estrogenic.

Authors:  Minerva Mercado-Feliciano; Robert M Bigsby
Journal:  Environ Health Perspect       Date:  2008-05       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.